Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of Naftopidil in male patients with lower urinary tract symptoms due to benign prostatic hyperplasia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

Drugs mentioned

• Naftopidil (Naftopidil)

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED